Pa Shun International Holdings Limited (0574.HK)
HKD 0.04
(0.0%)
HKD 0.04
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.1 Million CNY | 182.03% |
| 2022 | -4.99 Million CNY | 18.0% |
| 2021 | -6.09 Million CNY | -396.74% |
| 2020 | 2.05 Million CNY | -89.52% |
| 2019 | -171.35 Million CNY | 168.8% |
| 2018 | -26.85 Million CNY | -149.92% |
| 2017 | 40.16 Million CNY | -8.42% |
| 2016 | 62.33 Million CNY | -31.45% |
| 2015 | 90.93 Million CNY | -27.45% |
| 2014 | 125.33 Million CNY | 18.44% |
| 2013 | 105.81 Million CNY | 25.7% |
| 2012 | 84.18 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 54.5 Thousand CNY | 0.0% |
| 2024 Q1 | 54.5 Thousand CNY | 101.38% |
| 2023 Q3 | -3.94 Million CNY | -185.75% |
| 2023 Q4 | -3.94 Million CNY | 0.0% |
| 2023 FY | - CNY | 182.03% |
| 2023 Q2 | 4.6 Million CNY | 0.0% |
| 2023 Q1 | 4.6 Million CNY | 357.94% |
| 2022 Q4 | -1.78 Million CNY | 0.0% |
| 2022 Q3 | -1.78 Million CNY | -1240.26% |
| 2022 Q2 | 156.5 Thousand CNY | 0.0% |
| 2022 Q1 | 156.5 Thousand CNY | 103.73% |
| 2022 FY | - CNY | 18.0% |
| 2021 Q3 | -4.19 Million CNY | -142.97% |
| 2021 Q1 | -1.72 Million CNY | 35.38% |
| 2021 FY | - CNY | -396.74% |
| 2021 Q4 | -4.19 Million CNY | 0.0% |
| 2021 Q2 | -1.72 Million CNY | 0.0% |
| 2020 Q2 | -2.87 Million CNY | 0.0% |
| 2020 Q1 | -2.87 Million CNY | 25.14% |
| 2020 Q4 | -2.67 Million CNY | 0.0% |
| 2020 FY | - CNY | -89.52% |
| 2020 Q3 | -2.67 Million CNY | 7.01% |
| 2019 Q3 | -3.84 Million CNY | -190.64% |
| 2019 FY | - CNY | 168.8% |
| 2019 Q1 | 4.23 Million CNY | 143.18% |
| 2019 Q2 | 4.23 Million CNY | 0.0% |
| 2019 Q4 | -3.84 Million CNY | 0.0% |
| 2018 FY | - CNY | -149.92% |
| 2018 Q4 | -9.81 Million CNY | 0.0% |
| 2018 Q1 | 7.45 Million CNY | -22.33% |
| 2018 Q3 | -9.81 Million CNY | -231.66% |
| 2018 Q2 | 7.45 Million CNY | 0.0% |
| 2017 Q4 | 9.59 Million CNY | 0.0% |
| 2017 FY | - CNY | -8.42% |
| 2017 Q1 | 10.86 Million CNY | 15.23% |
| 2017 Q2 | 10.86 Million CNY | 0.0% |
| 2017 Q3 | 9.59 Million CNY | -11.69% |
| 2016 Q2 | 17.08 Million CNY | 0.0% |
| 2016 Q4 | 9.43 Million CNY | 0.0% |
| 2016 Q1 | 17.08 Million CNY | 9.71% |
| 2016 Q3 | 9.43 Million CNY | -44.81% |
| 2016 FY | - CNY | -31.45% |
| 2015 Q2 | 32.27 Million CNY | 0.0% |
| 2015 Q1 | 32.27 Million CNY | 1.14% |
| 2015 Q4 | 15.57 Million CNY | 0.0% |
| 2015 FY | - CNY | -27.45% |
| 2015 Q3 | 15.57 Million CNY | -51.74% |
| 2014 Q3 | 31.9 Million CNY | -1.45% |
| 2014 FY | - CNY | 18.44% |
| 2014 Q2 | 32.37 Million CNY | 0.0% |
| 2014 Q4 | 31.9 Million CNY | 0.0% |
| 2014 Q1 | 32.37 Million CNY | 49.75% |
| 2013 Q1 | 22.43 Million CNY | 0.0% |
| 2013 FY | - CNY | 25.7% |
| 2013 Q3 | 22.43 Million CNY | 0.0% |
| 2013 Q4 | 21.62 Million CNY | -3.6% |
| 2013 Q2 | 22.43 Million CNY | 0.0% |
| 2012 Q1 | 8.17 Million CNY | 0.0% |
| 2012 Q3 | 8.17 Million CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q4 | 22.43 Million CNY | 174.24% |
| 2012 Q2 | 8.17 Million CNY | 0.0% |
| 2011 Q4 | 8.17 Million CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| China Healthwise Holdings Limited | -117.45 Million HKD | 103.491% |
| Tycoon Group Holdings Limited | 147.38 Million HKD | 97.218% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 779.54 Million HKD | 99.474% |